DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 Listed Suppliers

1 API Suppliers
1 Listed Suppliers

MARKET PLACE

2 APIs

marketPlace
2 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 56302-13-7, Satranidazole [inn], 1-(1-methyl-5-nitroimidazol-2-yl)-3-methylsulfonylimidazolidin-2-one, 1-(1-methyl-5-nitro-1h-imidazol-2-yl)-3-(methylsulfonyl)-2-imidazolidinone, 4n7g8a6439, Satranidazol

Molecular Formula

C₈H₁₁N₅O₅S

Molecular Weight

289.27 g/mol

InChI Key

FNSHYEAUAUHIMB-UHFFFAOYSA-N

FDA UNII

4N7G8A6439

1 2D Structure

Satranidazole

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

1-(1-methyl-5-nitroimidazol-2-yl)-3-methylsulfonylimidazolidin-2-one

2.1.2 InChI

InChI=1S/C8H11N5O5S/c1-10-6(13(15)16)5-9-7(10)11-3-4-12(8(11)14)19(2,17)18/h5H,3-4H2,1-2H3

2.1.3 InChI Key

FNSHYEAUAUHIMB-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CN1C(=CN=C1N2CCN(C2=O)S(=O)(=O)C)[N+](=O)[O-]

2.2 Other Identifiers

2.2.1 UNII

4N7G8A6439

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 1-methanesulfonyl-3-(1-methyl-5-nitroimidazol-2-yl)-2-imidazolidinone

2. Cg-10213-go

3. Go 10213

4. Go-10213

2.3.2 Depositor-Supplied Synonyms

1. 56302-13-7

2. Satranidazole [inn]

3. 1-(1-methyl-5-nitroimidazol-2-yl)-3-methylsulfonylimidazolidin-2-one

4. 1-(1-methyl-5-nitro-1h-imidazol-2-yl)-3-(methylsulfonyl)-2-imidazolidinone

5. 4n7g8a6439

6. Satranidazol

7. Satranidazol [spanish]

8. Satranidazolum

9. Satranidazolum [latin]

10. 1-(1-methyl-5-nitro-1h-imidazol-2-yl)-3-(methylsulfonyl)imidazolidin-2-one

11. Go 10213

12. C 10213 Go

13. Go-10213

14. Brn 0848345

15. Unii-4n7g8a6439

16. 1-methylsulfonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone

17. 2-imidazolidinone, 1-(1-methyl-5-nitro-1h-imidazol-2-yl)-3-(methylsulfonyl)-

18. 5-25-09-00447 (beilstein Handbook Reference)

19. Satranidazole [mart.]

20. Satranidazole [who-dd]

21. Schembl1682863

22. Chembl2105542

23. Dtxsid60204840

24. C-10213-go

25. Zinc4217442

26. 1-(1-methyl-5-nitroimidazol-2-yl)-3-(methylsulfonyl)-2-imidazolidinone

27. A924024

28. Q27260233

29. 3-(1-methyl-5-nitroimidazol-2-yl)-1-methylsulfonyl-imidazolidin-2-one

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₈H₁₁N₅O₅S
Molecular Weight	289.27 g/mol
XLogP3	-0.8
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	2
Exact Mass	289.04808964 g/mol
Monoisotopic Mass	289.04808964 g/mol
Topological Polar Surface Area	130 Å²
Heavy Atom Count	19
Formal Charge	0
Complexity	497
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1